Home » Poll Results » October 2020 Question of the Month

October 2020 Question of the Month

What change do you most expect to see in the 340B program in the next year?

Reduced drug sales at 340B prices: 60%

Legislative changes to 340B program: 20%

HRSA lawsuit challenging 340B sales limitations by manufacturers: 20%

Shifting drug sales to 340B supportive manufacturers: 0%

February 2021 Question of the Month Results

What will be the greatest limitation(s) in the COVID19 vaccine rollout in the US?

Patient ability to navigate the entire process: 26.32%

Patient acceptance of vaccine: 21.05%

Distribution/Administration: 21.05%

Vaccine supply: 15.79%

Procedural differences from state to state: 10.53%

Systems used to set up vaccination appointments: 5.26%

Proper interpretation of the rules for each phase: 0.00%

2022 or later: 62.5%

How will Amazon Pharmacy impact the pharmacy market in the next 5 years?

Competitive force influencing incumbents: 66.7%

Disruptive force: 25%

Market participant, no disruption: 8.3%

No longer participating: 0%